Qiagen stock slightly lower pre-market: science and health group at EUR 40.94
Published on 10/19/2026 at 07:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSScience market and morning price
- Qiagen serves science and health markets with products and solutions for research and clinical applications.
- The relevant benchmark is the S&P 500.
- Qiagen stock trades pre-market at EUR 40.94 at 7:35 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.22 percent below the Xetra close of October 16, 2026.
Qiagen serves science and health markets with products and solutions for research and clinical applications, according to its Investor Relations materials. Qiagen stock trades pre-market at EUR 40.94 at 7:35 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.22 percent below the Xetra close of October 16, 2026 (EUR 41.03).
Ahead of the Xetra open
The indication is EUR 0.09 below Friday's Xetra closing level. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.
Qiagen's operating focus
QIAGEN's investor-relations materials describe digital PCR applications spanning research and clinical settings. The company also highlights its customer base, operating strategy, cash flow and capital allocation on the same page. Market context: Market report S&P 500.
